Ligand Pharmaceuticals Incorporated

NasdaqGM:LGND Stock Report

Market Cap: US$2.2b

Ligand Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:LGND Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Sep 24SellUS$134,603Matthew KorenbergIndividual1,293US$104.10
20 Sep 24SellUS$132,518Octavio EspinozaIndividual1,275US$103.98
26 Aug 24SellUS$1,986,420Matthew KorenbergIndividual18,858US$106.32
09 Aug 24SellUS$1,797,133Matthew KorenbergIndividual18,245US$98.50
08 Aug 24BuyUS$243,481Todd DavisIndividual2,500US$97.39
16 May 24SellUS$699,860Octavio EspinozaIndividual8,137US$86.01
14 May 24SellUS$1,495,740Matthew KorenbergIndividual17,598US$85.68
09 May 24SellUS$77,713Nancy GrayIndividual934US$83.20

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LGND?
Owner TypeNumber of SharesOwnership Percentage
State or Government7,1800.0374%
Individual Insiders366,6421.91%
Institutions18,803,77698.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.4%.

Top Shareholders

Top 25 shareholders own 75.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.9%
BlackRock, Inc.
2,999,632US$343.9m4.46%0.01%
10.4%
The Vanguard Group, Inc.
1,970,622US$225.9m2.27%no data
5.34%
Janus Henderson Group plc
1,009,094US$115.7m0.04%0.05%
4.7%
Macquarie Investment Management Business Trust
887,275US$101.7m-8.2%0.12%
3.74%
State Street Global Advisors, Inc.
707,414US$81.1m2.71%no data
3.74%
Dimensional Fund Advisors LP
707,016US$81.1m-0.23%0.01%
3.27%
Stephens Investment Management Group, LLC
618,696US$70.9m-5.11%0.95%
3.2%
Congress Asset Management Company, LLP
604,038US$69.2m2.97%0.46%
2.89%
Chicago Capital, LLC
545,821US$62.6m6%1.66%
2.51%
St. Denis J. Villere & Co., LLC
474,858US$54.4m-1.87%4.91%
2.27%
Geode Capital Management, LLC
428,270US$49.1m5.54%no data
1.97%
Loomis Sayles & Company, L.P.
372,779US$42.7m44.3%0.05%
1.66%
Rice Hall James & Associates, LLC
312,879US$35.9m6.98%1.92%
1.64%
Ashford Capital Management Inc
310,407US$35.6m-3.66%4.09%
1.48%
Impax Asset Management Group Plc
280,208US$32.1m0%0.09%
1.45%
Deutsche Asset & Wealth Management
273,892US$31.4m1.36%0.01%
1.4%
DWS Investment Management Americas, Inc.
264,100US$30.3m0.55%0.14%
1.39%
Northern Trust Global Investments
262,750US$30.1m28.2%no data
1.32%
abrdn plc
249,269US$28.6m-7.73%0.02%
1.14%
William Blair Investment Management, LLC
214,904US$24.6m1.38%0.03%
0.94%
Invesco Capital Management LLC
176,760US$20.3m10.1%0.01%
0.87%
Charles Schwab Investment Management, Inc.
163,924US$18.8m5.53%no data
0.72%
Morgan Stanley, Investment Banking and Brokerage Investments
136,474US$15.6m43.4%no data
0.72%
Kornitzer Capital Management, Inc.
135,482US$15.5m0%0.26%
0.71%
F/M Investments LLC
134,299US$15.4m-0.31%0.52%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ligand Pharmaceuticals Incorporated is covered by 22 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Balaji PrasadBarclays
Balaji PrasadBarclays